200 related articles for article (PubMed ID: 21498100)
1. GH receptor blocker administration and muscle-tendon collagen synthesis in humans.
Nielsen RH; Doessing S; Goto K; Holm L; Reitelseder S; Agergaard J; Schjerling P; Flyvberg A; Kjaer M
Growth Horm IGF Res; 2011 Jun; 21(3):140-5. PubMed ID: 21498100
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.
Doessing S; Heinemeier KM; Holm L; Mackey AL; Schjerling P; Rennie M; Smith K; Reitelseder S; Kappelgaard AM; Rasmussen MH; Flyvbjerg A; Kjaer M
J Physiol; 2010 Jan; 588(Pt 2):341-51. PubMed ID: 19933753
[TBL] [Abstract][Full Text] [Related]
3. Effect of growth hormone on aging connective tissue in muscle and tendon: gene expression, morphology, and function following immobilization and rehabilitation.
Boesen AP; Dideriksen K; Couppé C; Magnusson SP; Schjerling P; Boesen M; Aagaard P; Kjaer M; Langberg H
J Appl Physiol (1985); 2014 Jan; 116(2):192-203. PubMed ID: 24235105
[TBL] [Abstract][Full Text] [Related]
4. GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients.
Doessing S; Holm L; Heinemeier KM; Feldt-Rasmussen U; Schjerling P; Qvortrup K; Larsen JO; Nielsen RH; Flyvbjerg A; Kjaer M
Eur J Endocrinol; 2010 Dec; 163(6):853-62. PubMed ID: 20858702
[TBL] [Abstract][Full Text] [Related]
5. GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans.
Heinemeier KM; Mackey AL; Doessing S; Hansen M; Bayer ML; Nielsen RH; Herchenhan A; Malmgaard-Clausen NM; Kjaer M
Scand J Med Sci Sports; 2012 Aug; 22(4):e1-7. PubMed ID: 22429205
[TBL] [Abstract][Full Text] [Related]
6. Chronic alterations in growth hormone/insulin-like growth factor-I signaling lead to changes in mouse tendon structure.
Nielsen RH; Clausen NM; Schjerling P; Larsen JO; Martinussen T; List EO; Kopchick JJ; Kjaer M; Heinemeier KM
Matrix Biol; 2014 Feb; 34():96-104. PubMed ID: 24080228
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy.
Yin D; Vreeland F; Schaaf LJ; Millham R; Duncan BA; Sharma A
Clin Cancer Res; 2007 Feb; 13(3):1000-9. PubMed ID: 17289896
[TBL] [Abstract][Full Text] [Related]
8. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice.
McCutcheon IE; Flyvbjerg A; Hill H; Li J; Bennett WF; Scarlett JA; Friend KE
J Neurosurg; 2001 Mar; 94(3):487-92. PubMed ID: 11235955
[TBL] [Abstract][Full Text] [Related]
10. Tendon and skeletal muscle matrix gene expression and functional responses to immobilisation and rehabilitation in young males: effect of growth hormone administration.
Boesen AP; Dideriksen K; Couppé C; Magnusson SP; Schjerling P; Boesen M; Kjaer M; Langberg H
J Physiol; 2013 Dec; 591(23):6039-52. PubMed ID: 24081158
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
Nielsen C; Gormsen LC; Jessen N; Pedersen SB; Møller N; Lund S; Jørgensen JO
J Clin Endocrinol Metab; 2008 Jul; 93(7):2842-50. PubMed ID: 18460563
[TBL] [Abstract][Full Text] [Related]
12. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
[TBL] [Abstract][Full Text] [Related]
13. Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women.
Hansen M; Miller BF; Holm L; Doessing S; Petersen SG; Skovgaard D; Frystyk J; Flyvbjerg A; Koskinen S; Pingel J; Kjaer M; Langberg H
J Appl Physiol (1985); 2009 Apr; 106(4):1435-43. PubMed ID: 18845777
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
[TBL] [Abstract][Full Text] [Related]
15. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
[TBL] [Abstract][Full Text] [Related]
16. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
Wilson ME
J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
[TBL] [Abstract][Full Text] [Related]
17. Local administration of growth hormone stimulates tendon collagen synthesis in elderly men.
Vestergaard P; Jørgensen JO; Olesen JL; Bosnjak E; Holm L; Frystyk J; Langberg H; Kjaer M; Hansen M
J Appl Physiol (1985); 2012 Nov; 113(9):1432-8. PubMed ID: 22961272
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon.
Olesen JL; Heinemeier KM; Haddad F; Langberg H; Flyvbjerg A; Kjaer M; Baldwin KM
J Appl Physiol (1985); 2006 Jul; 101(1):183-8. PubMed ID: 16782835
[TBL] [Abstract][Full Text] [Related]
20. Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD).
Berg CA; Pokrajac A; Bidlingmaier M; Strasburger CJ; Shalet SM; Trainer PJ
Clin Endocrinol (Oxf); 2009 Mar; 70(3):439-45. PubMed ID: 19067728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
